Dr. Mark S. Amorosino, MD

Dr. Amorosino practices at Gastro Health in Palm Beach Gardens, Florida.

Dr. Amorosino's NPI, 1316068554, was assigned on April 3, 2007. Dr. Amorosino graduated from Boston University School Of Medicine in 2000. Dr. Amorosino holds Florida license ME140931.

Dr. Amorosino's primary practice is Gastro Health, at 3375 Burns Rd, Palm Beach Gardens, FL 33410 in Palm Beach County. The practice phone is (954) 433-5900.

Dr. Amorosino's primary practice is Gastro Health in Palm Beach Gardens, Florida. Dr. Amorosino is also affiliated with Palm Beach Gardens Medical Center. The medical group on file is Gastro Health. Dmand AI also links Dr. Amorosino to 2 more hospitals, 1 group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Amorosino practices, 4 sites in all. Vendor and product names are available with a free account.

Gastroenterology is Dr. Amorosino's primary specialty in the NPI Registry, under taxonomy code 207RG0100X. Dr. Amorosino is board certified in gastroenterology by the American Board of Internal Medicine. Dmand AI has Dr. Amorosino's licenses on file in 3 states: Florida, Massachusetts and Virginia.

Dmand AI lists acid reflux, acute gastroduodenitis, chronic inflammatory bowel disease (IBD), cirrhosis of the liver, colonoscopy, gastroenteritis, gastrointestinal bleeding and hemorrhoids among the conditions Dr. Amorosino treats.

CMS data shows 1,249 Medicare services from Dr. Amorosino across 14 procedure codes in 2024, for 472 Medicare patients. Medicare paid $110,477 for them.

CMS counts 472 Medicare patients who saw Dr. Amorosino in 2024. The largest group is 75 to 84, with 193 patients. 75% of them have high cholesterol, and 74% have high blood pressure. 8% are also on Medicaid. Their average risk score is 1.43, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Amorosino's median patient age at 59, with 55% women.

In 2024, Dr. Amorosino wrote 920 Medicare Part D claims for 314 patients. 75% of them were for generic drugs. CMS names the drug for 751 of them, across 16 drugs with 11 or more claims each, at $267,297 in total drug cost. In 2023, CMS named 743 claims across 17 drugs.

Dr. Amorosino accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Amorosino as offering telehealth. CMS counts 114 procedures of upper gastrointestinal (gi) endoscopy for acid reflux by Dr. Amorosino, more than 79% of the clinicians it reports for that procedure.

Dmand AI links 3 papers to Dr. Amorosino. Dr. Amorosino's most frequent co-author is Francis A. Farraye, MD.

CMS Open Payments shows 765 general payments to Dr. Amorosino from 44 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 89% of the total. Abbvie Inc. paid the most, $3,005.

Dmand AI lists 1 award for Dr. Amorosino, most recently CMS Stage 1 EHR in 2013.

Dr. Amorosino graduated from Boston University School Of Medicine in 2000. Dr. Amorosino is a member of ACG and ASGE.

Dr. Amorosino is in network with 19 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. PPO plans come from the most carriers, 12. Check the plan with the practice before a visit.